Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →
Virtus LifeSci Biotech Products ETF (BBP) belongs to the Tomorrow's Treatments segment. SPDR S&P Pharmaceuticals ETF (XPH) is part of the US Health Care segment. Both ETFs have the same top 3 sector exposures: and Health Care. BBP is more expensive with a Total Expense Ratio (TER) of 0.79%, versus 0.35% for XPH. BBP is up 5.62% year-to-date (YTD) with +$4M in YTD flows. XPH performs worse with -5.13% YTD performance, and +$96M in YTD flows. Run a side-by-side ETF comparison of BBP and XPH below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | BBP XPH | +2.73%-6.46% | +7.35%-4.96% | +5.62%-5.13% | +41.19%+26.10% | +72.79%+37.18% | +54.18%+4.53% |
| Flows | BBP XPH | +$4M+$20M | +$16M+$103M | +$4M+$96M | +$19M+$121M | +$19M+$56M | +$9M+$44M |
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | BBP XPH | +24.64%+21.49% | +25.49%+23.31% | +23.37%+19.10% | +26.10%+20.31% |
| Max drawdown | BBP XPH | -7.42%-8.79% | -17.97%-17.10% | -25.54%-23.45% | -38.24%-32.89% |
| Max drawdown duration | BBP XPH | 32d16d | 106d140d | 292d322d | 915d1703d |
BBP | XPH | |
Last sale 3/13/2026 at 1:30 PM | $81.25 | $53.25 |
| Previous close 03/12/2026 | $81.68 | $53.64 |
| Consolidated volume 03/12/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Create an account to view replication metrics
BBP | XPH | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
BBP | XPH | |
|---|---|---|
| Last price | $81.25 | $53.25 |
| 1D performance | -0.53% | -0.73% |
| AuM | $50.55 M | $308.63 M |
| E/R | 0.79% | 0.35% |
BBP | XPH | |
|---|---|---|
| Management strategy | Passive | Passive |
| Provider | VIRTUS Investment Partners | SPDR |
| Benchmark | LifeSci Biotechnology Products Index | S&P Pharmaceuticals Select Industry Index |
| N° of holdings | 58 | 49 |
| Asset class | Equities | Equities |
| Trailing 12m distribution yield | Join | Join |
| Inception date | December 16, 2014 | June 19, 2006 |
| ESG | No | No |
Total weight of top 15 holdings out of 15
Total weight of top 15 holdings out of 15
Compare ETFs like a pro. Analyze fees, performance, exposure & holdings side-by-side.